A combination of YM-155, a small molecule survivin inhibitor, and IL-2 potently suppresses renal cell carcinoma in murine model

YM155, a small molecule inhibitor of the antiapoptotic protein survivin, has been developed as a potential anti-cancer drug. We investigated a combination therapy of YM155 and interleukin-2 (IL-2) in a mouse model of renal cell carcinoma (RCC). YM155 caused cell cycle arrest and apoptosis in renal c...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Kai, Huang, Peng, Xu, Naijin, Xu, Peng, Kaku, Haruki, Zheng, Shaobo, Xu, Abai, Matsuura, Eiji, Liu, Chunxiao, Kumon, Hiromi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673255/
https://www.ncbi.nlm.nih.gov/pubmed/26023798

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673255/
https://www.ncbi.nlm.nih.gov/pubmed/26023798

Ejemplares similares